全部

1·Others think Novartis has paid too much.

也有人认为诺华付的太多了。

2·Both Novartis and GSK say they are thinking along these lines.

诺华和史克公司都表示它们也在考虑差别定价的问题。

3·Agilent and Novartis like to turn specialists into general managers.

安捷伦和诺华喜欢将专家转变为总经理。

4·Novartis will sell its drug under the brand name Gilenya in the U.S..

诺华公司的该药物在美国市场的商品名为Gilenya。

5·NOVARTIS, a Swiss pharmaceuticals giant, is involved in two deals at the moment.

瑞士制药巨头诺华公司目前卷入两笔交易。

6·Pfizer and Novartis have formed their own biotech divisions, and Allergan will surely follow.

辉瑞和诺华制药已经设立了各自的生物科技部门，爱力根也一定会紧跟其后。

7·Novartis hopes to have the pills in front of European regulators for assessment within 18 months.

诺华公司希望在18个月内能把这种药片呈送欧洲监管机构进行评估。

8·Novartis, a Swiss drugs giant, paid some $5.7 billion to finalise its acquisition of Chiron last year.

瑞士药业巨头诺华制药（Novaritis）去年耗资57亿美元，并购了凯龙公司（Chiron）。

9·Paul Herrling of Novartis points out that virally induced cancers are rare in Europe but common in China.

诺华公司的Paul Herrling指出病毒诱发性的癌症在欧洲很罕见但是在中国却很常见.

10·Questions remain, however, as to whether Novartis can still force its offer through without the committee's approval.

然而，在没有这个委员会允许的情况下，诺华是否能够继续进行收购的这个问题还没有解决。